UBASH3B and neoplasm: In contrast, Kaplan–Meier analysis showed that the 5-year overall survival of PCa patients with high UBASH3B expression levels was significantly shorter than that of patients with low UBASH3B levels, which may be a potential prognostic biomarker and correlated with tumor-infiltrating immune cells in the tumor microenvironment [7].